Robert E. Marcus, MA, FRCP, FRCPath
Consultant Haematologist, Lead Cancer Clinician
Kings College Hospital
Consultant Haematologist
London Oncology Clinic
London, United Kingdom

Robert E. Marcus, MA, FRCP, FRCPath is consultant haematologist and lead cancer clinician at King's College Hospital United Kingdom. Dr Marcus received his medical degree from the University College Hospital Medical School in London and completed specialized hematology training at University College Hospital and a research fellowship in the MRC Leukemia Unit at the Royal Postgraduate Medical School at Hammersmith Hospital in London. Prior to joining King’s College Hospital in 2008, Dr Marcus was consultant haematologist in Addenbrookes Hospital in Cambridge, United Kingdom for 20 years where he established the bone marrow transplant unit, and developed his specialist interest in lymphoma.

Dr Marcus’ research interests include development of novel therapies for lymphoma. He participated in the first clinical studies in monoclonal antibody therapy for lymphoma with the CAMPATH series of antibodies and has been chief investigator in a large number of phase II and III studies on chemotherapy and immunotherapy in lymphoma.

Dr Marcus is the chairman of the NCRI low-grade lymphoma working party and has chaired numerous review groups and is an examiner for the Royal College of Pathologists. In addition, he is medical advisor to the Lymphoma Association and vice president of the Leukaemia Care Society. Dr Marcus served on the editorial board of Bone Marrow Transplantation and has authored more than 140 peer-reviewed manuscripts and review articles. In addition, he has co-edited three books including, most recently, a new standard textbook on lymphoma, which is currently being revised for the second edition.